These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28416594)

  • 21. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.
    Brody AL; Mandelkern MA; Olmstead RE; Scheibal D; Hahn E; Shiraga S; Zamora-Paja E; Farahi J; Saxena S; London ED; McCracken JT
    Arch Gen Psychiatry; 2006 Jul; 63(7):808-16. PubMed ID: 16818870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability.
    Shumay E; Fowler JS; Wang GJ; Logan J; Alia-Klein N; Goldstein RZ; Maloney T; Wong C; Volkow ND
    Transl Psychiatry; 2012 Mar; 2(3):e86. PubMed ID: 22832851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.
    Chen YW; Kao HY; Min MY; Lai WS
    Schizophr Bull; 2014 Mar; 40(2):388-98. PubMed ID: 23474853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET Study.
    Smigielski L; Wotruba D; Treyer V; Rössler J; Papiol S; Falkai P; Grünblatt E; Walitza S; Rössler W
    Schizophr Bull; 2021 Aug; 47(5):1495-1508. PubMed ID: 33876249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.
    Hirvonen M; Laakso A; Någren K; Rinne JO; Pohjalainen T; Hietala J
    Mol Psychiatry; 2004 Dec; 9(12):1060-1. PubMed ID: 15278099
    [No Abstract]   [Full Text] [Related]  

  • 27. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
    Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
    Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
    Ashok AH; Mizuno Y; Volkow ND; Howes OD
    JAMA Psychiatry; 2017 May; 74(5):511-519. PubMed ID: 28297025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
    Abi-Dargham A; Gil R; Krystal J; Baldwin RM; Seibyl JP; Bowers M; van Dyck CH; Charney DS; Innis RB; Laruelle M
    Am J Psychiatry; 1998 Jun; 155(6):761-7. PubMed ID: 9619147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status.
    Wiers CE; Cabrera EA; Tomasi D; Wong CT; Demiral ŞB; Kim SW; Wang GJ; Volkow ND
    Neuropsychopharmacology; 2017 Nov; 42(12):2325-2332. PubMed ID: 28643800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine release.
    Wai JM; Grassetti A; Slifstein M; Matuskey D; Nabulsi N; Ropchan J; Labaree D; Huang Y; Martinez D
    Drug Alcohol Depend; 2019 Dec; 205():107627. PubMed ID: 31669800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
    van Dyck CH; Malison RT; Jacobsen LK; Seibyl JP; Staley JK; Laruelle M; Baldwin RM; Innis RB; Gelernter J
    J Nucl Med; 2005 May; 46(5):745-51. PubMed ID: 15872345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
    Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment.
    Tan HY; Chen AG; Kolachana B; Apud JA; Mattay VS; Callicott JH; Chen Q; Weinberger DR
    Brain; 2012 May; 135(Pt 5):1436-45. PubMed ID: 22525159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.
    Stokes PR; Egerton A; Watson B; Reid A; Lappin J; Howes OD; Nutt DJ; Lingford-Hughes AR
    J Psychopharmacol; 2012 Jan; 26(1):144-9. PubMed ID: 21890594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia.
    Martikainen IK; Hagelberg N; Mansikka H; Hietala J; Någren K; Scheinin H; Pertovaara A
    Neurosci Lett; 2005 Mar; 376(3):149-53. PubMed ID: 15721212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal D1 and D2 receptor availability are selectively associated with eye-blink rates after methylphenidate treatment.
    Demiral ŞB; Manza P; Biesecker E; Wiers C; Shokri-Kojori E; McPherson K; Dennis E; Johnson A; Tomasi D; Wang GJ; Volkow ND
    Commun Biol; 2022 Sep; 5(1):1015. PubMed ID: 36163254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
    Heinz A; Siessmeier T; Wrase J; Buchholz HG; Gründer G; Kumakura Y; Cumming P; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
    Am J Psychiatry; 2005 Aug; 162(8):1515-20. PubMed ID: 16055774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [
    Girgis RR; Slifstein M; Brucato G; Kegeles LS; Colibazzi T; Lieberman JA; Abi-Dargham A
    Mol Psychiatry; 2021 Jun; 26(6):2504-2513. PubMed ID: 33154566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism in the ZNF804A Gene and Variation in D
    Hegarty CE; Ianni AM; Kohn PD; Kolachana B; Gregory M; Masdeu JC; Eisenberg DP; Berman KF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Jan; 8(1):121-128. PubMed ID: 33712377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.